Product Code: RP-ID-10151825 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10151825
Market Overview:
Global Anti-Adhesion Products Industry Market Research 2022-2030
" The global anti-adhesion products market is expected to reach at a value of more than ~USD 1 billion by the end of 2030 expanding at a CAGR of 8% over the period 2022-2030. Adhesions are wounds made of sticky tissue that form in the body and connect tissues to internal organs. This can be annoying because it blocks internal organs and causes pain in this area. Postoperative adhesions occur at the surgical site as part of the healing process, but can spread to other parts of the body and cause complications. Release products are sold in a variety of formulations including gels, films, and liquids. Gels and films are preferred over liquid formulations because they are more effective than liquid release agents.
The anti-adhesion market is evolving with various surgical interventions in the medical field. These interventions include orthopedic surgery, obstetrics and gynecology, cardiovascular surgery, and general abdominal surgery. The rise of the elderly and rising sports injuries should also drive the market.
The use of non-stick products is controversial in terms of clinical safety and efficacy as surgeons are reluctant to use non-stick products. Although there are no drugs available to treat adhesions and non-adhesive products are the only treatment option, this is a market limitation. Several innovative products have been introduced to ensure the safety and effectiveness of market growth forecasting.
Product Overview:
The Sealing Tapes industry segment is expected to witness the fastest growth during the forecast period. The polyethylene glycol (PEG) product portfolio dominates the global market and is projected to grow at a CAGR of 5% during the forecast period. The industry will have a population of 239.2 million in 2019 and is expected to grow faster than other therapies due to this. Several international meta-analyses have shown that approved PEG-based anti-adhesion products significantly reduce postoperative adhesions in women. Other types of products such as hyaluronic acid and renewable cellulose are expected to witness significant growth over the forecast period.
Formulation Overview:
The gel formulation industry is projected to grow at a significant CAGR from 2022 to 2030 owing to increasing demand and strength of formulations. The global market for non-stick products is purposefully growing with the advent of female pelvic reconstructive surgery, creating more and more market opportunities. The Asia Pacific region is expected to dominate the gel formulation market owing to the increase in geriatric surgery.
Application Forecast:
Cardiovascular surgery is expected to be a key factor in the forecast segment with a CAGR of ~8%. Postoperative adhesions occur in approximately 90% of cases of market-related surgery, gynecological surgery, and market-related cardiovascular surgery. Due to the expansion of the market, approximately 250 million transactions are made each year. Cardiovascular surgery maximizes the use of nonstick products, especially in coronary artery treatment.
Regional Outlook:
Growing demand from North America led the market with revenue of USD 200 million in 2020. North America has the highest percentage of non-stick products, with a CAGR of 6%. North America is a driving force for medical and technological developments leading to innovative products. It also helps to have a large number of important players on the ground. Asia Pacific region is a promising target market with the highest growth rate of 7% per year and high share in 2021.
The Asia Pacific region has a large elderly population and growing problems with surgery and transplantation. The increasing number of patients with different types of heart and gastrointestinal problems is restraining the Asian addiction industry and providing opportunities in European, Latin American and Middle Eastern markets.
Future growth potential. Countries such as Brazil, South Africa, UAE, Germany, UK and France have adopted fast food practices that can lead to more surgeries. However, in the European market, some form of sealant is used instead of non-stick products, and non-stick products are not used for safety reasons. Several release agents have been approved for the treatment of postoperative adhesions in this area.
North America is projected to reach a thriving market share of 37% by 2030. Growth in medical development, increased investment and technological advances are the driving forces behind this sector. Adhesive products such as polyethylene glycol, which account for 43.4% of the total, are widely used because they must be effective.
Non-stick products are widely used in cardiovascular diseases with a growth rate of 7.0 years per year, followed by orthopedics, gynecology and abdominal surgery. The market is located in the Asia Pacific region with a high CAGR. Awareness of member-related diseases has increased in India, China and Australia among 8 to 3 people due to an aging population. The Asia Pacific region is expected to grow thanks to Niwatokos business expansion. This is because the natural formulations market for non-stick products is growing at a compound annual growth rate of 6%.
Companies interviewed and identified in this market study are Johnson :
Johnson, Sanofi SA, Baxter International and Inc. Summary of Report by Becton Dickinson & Company, Anika Therapeutics Inc., Ethicon, Faziomed, Integra Lifesciences Corporation, Mast Biosurgery, Terumo Corporation, BMI Korea Co. They are the major players in the market and players in this segment have focused on different strategies to strengthen their position in the market during the 2022-2030 period.
The important points are: December 2019, Baxter International Inc. GmbH. Ltd., a leading medical device company, has acquired the related assets of Seprafilm Adhesion Barrier and Sanofi A. The acquisition was a strategic step to expand the Adhesion Barrier product portfolio. FzioMed has launched an industrial adhesive called Oxiplex/IU. This product is CE marked and approved for sale in the European Union. This soft, viscous, absorbable gel is used during intrauterine surgery to improve surgical outcomes while maintaining uterine integrity and reducing post-operative adhesions.
Landscape Trading:
Mergers and acquisitions are an integral part of the release industry. In addition to the companies operating in this sector, other major players are joining the sector.
Expert Comment:
The report and data recognize positive developments in the industry to improve the performance of non-stick products in post-operative custody conditions. Companies are developing new products with improved performance in line with the expectations of existing customers with better clinical outcomes. According to industry analysts, new entrants are expected to enter the industry, which could change the nature of the business. Newcomers will focus on implementing innovative technologies while reducing complexity and total cost of ownership.
The scope of the report can be defined as follows:
For the comprehensive analysis of this report, the report and data on the global Anti Aging Market are segmented by product type, treatment type, application, and region.
Product Overview:
(USD 1 million, 2022-2030): Synthetic Sutures, Polyethylene Glycol, Hyaluronic Acid, Renewable Cellulose, Natural Adhesive Barriers, Collagen and Protein, Fibrin, Uses (USD 1 Million, 2022-2030)
Heart and Vascular surgery, cardiovascular surgery, orthopedics and abdominal surgery. 2022-2030): liquid film"
Related Reports
Proof of Quality & Reliability
